For research use only. Not for therapeutic Use.
Defluoro-MDV 3100 (Defluoro-enzalutamide) is an impurity of Enzalutamide , which is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. Enzalutamide has been shown to induce tumor cell apoptosis, and is used for the treatment of castration-resistant prostate cancer.
Catalog Number | C000402 |
CAS Number | 915087-16-0 |
Synonyms | 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-N-methylbenzamide; 4-[3-(4-Cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]-N-methylbenzamide; |
Molecular Formula | C₂₁H₁₇F₃N₄O₂S |
Purity | ≥95% |
Solubility | Acetone (Slightly), Chloroform (Slightly) |
Appearance | Pale Yellow to Light Yellow Solid |
Storage | 4°C, Inert atmosphere |
Reference | Scher, H.I. et al.: Lancet, 375, 1437 (2010); Bellmunt, J. et al.: Ther. Adv. Med. Oncol., 2, 189 (2010); Ryan, C.J. et al.: J. Clin. Oncol., 29, 3651 (2011); Ma, X., et al.: J. Pharm. Biomed. Anal., 131, 436 (2016); |